Continued-Maintenance Therapy with High-dose Methotrexate Improves Overall Survival of Patients with Primary Central Nervous System Lymphoma
Author:
Affiliation:
1. Department of Neurosurgery, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan, Tokushima, 770-8503, Japan
Publisher
University of Tokushima Faculty of Medicine
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://www.jstage.jst.go.jp/article/jmi/68/3.4/68_286/_pdf
Reference20 articles.
1. 1. Grommes C, DeAngelis LM : Primary CNS Lymphoma. J Clin Oncol 35 : 2410-2418, 2017
2. 2. Bairey O, Siegal T : The possible role of maintenance treatment for primary central nervous system lymphoma. Blood Rev 32 : 378-386, 2018
3. 3. Gavrilovic IT, Hormigo A, Yahalom J, DeAngelis LM, Abrey LE : Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 24 : 4570-4, 2006
4. 4. Birnbaum T, Bochmann K, von Baumgarten L, Straube A : Early relapses in patients with primary CNS lymphoma treated with methotrexate-based chemotherapy without consolidating whole brain irradiation. J Neurooncol 112 : 233-9, 2013
5. 5. Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, Frenay M, De Beule N, Delattre JY, Baron B : Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years : a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol 21 : 2726-31, 2003
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The notable outcomes of modified thiotepa-based conditioning followed by autologous stem cell transplantation in primary central nervous system lymphomas: A real-life pilot study;2024-05-31
2. Challenging Cases in Neuro-Oncology;Seminars in Neurology;2022-11-23
3. Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review;Frontiers in Oncology;2022-11-17
4. Methotrexate;Reactions Weekly;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3